Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update

Rockwell Medical, Inc. (NASDAQ:RMTI) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 617,500 shares, a decrease of 28.5% from the December 15th total of 863,900 shares. Approximately 2.2% of the shares of the company are sold short. Based on an average trading volume of 708,000 shares, the short-interest ratio is presently 0.9 days.

Rockwell Medical Stock Performance

RMTI traded up $0.02 during trading on Friday, hitting $2.12. The company’s stock had a trading volume of 171,584 shares, compared to its average volume of 311,262. The business’s 50 day simple moving average is $2.24 and its 200-day simple moving average is $2.74. The firm has a market cap of $68.52 million, a PE ratio of -42.40 and a beta of 1.38. Rockwell Medical has a one year low of $1.16 and a one year high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33.

Analyst Upgrades and Downgrades

RMTI has been the subject of several research reports. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. HC Wainwright reiterated a “buy” rating and set a $7.00 target price on shares of Rockwell Medical in a research note on Monday, December 23rd. Rodman & Renshaw assumed coverage on Rockwell Medical in a research note on Thursday, November 14th. They issued a “buy” rating and a $5.00 price target on the stock. Finally, StockNews.com cut Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Concurrent Investment Advisors LLC bought a new stake in shares of Rockwell Medical during the 3rd quarter valued at $40,000. Verus Capital Partners LLC bought a new stake in Rockwell Medical during the third quarter valued at about $51,000. Barclays PLC bought a new position in shares of Rockwell Medical in the third quarter worth about $90,000. Beacon Financial Advisory LLC purchased a new stake in shares of Rockwell Medical during the third quarter worth about $98,000. Finally, XTX Topco Ltd grew its position in shares of Rockwell Medical by 45.7% during the third quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after purchasing an additional 8,922 shares in the last quarter. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.